Patents by Inventor Martin Ronald Webb

Martin Ronald Webb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8188225
    Abstract: Binding of inorganic phosphate to a phosphate binding protein can result in changes to the stacking of appropriately positioned chromophores, thereby resulting in a detectable change. The invention provides a phosphate-binding protein that undergoes a conformational change from an initial conformation to a final conformation upon binding of phosphate, wherein the protein carries a first label and a second label, and wherein the first and second labels are arranged such that they exhibit molecular stacking that is perturbed on changing from one conformation to the other. Preferred labels are rhodamines.
    Type: Grant
    Filed: August 31, 2006
    Date of Patent: May 29, 2012
    Assignee: Medical Research Council
    Inventors: John Edgar Thomas Corrie, Martin Ronald Webb, Michael Prince Okoh
  • Publication number: 20100022017
    Abstract: Binding of inorganic phosphate to a phosphate binding protein can result in changes to the stacking of appropriately positioned chromophores, thereby resulting in a detectable change. The invention provides a phosphate-binding protein that undergoes a conformational change from an initial conformation to a final conformation upon binding of phosphate, wherein the protein carries a first label and a second label, and wherein the first and second labels are arranged such that they exhibit molecular stacking that is perturbed on changing from one conformation to the other. Preferred labels are rhodamines.
    Type: Application
    Filed: August 31, 2006
    Publication date: January 28, 2010
    Inventors: John Edgar Thomas Corrie, Martin Ronald Webb, Michael Prince Okoh
  • Patent number: 7297506
    Abstract: Nucleoside diphosphates (NDPs) are detected or measured by following the dephosphorylation of the phosphoenzyme form of nucleoside diphosphate kinase (NDPK), and nucleoside triphosphates (NTPs) are detected or measured by following the phosphorylation of NDPK to its phosphoenozyme form. A typical process involves (a) causing NDP in sample to bind to NDPK phosphoenzyme, or causing NTP in sample to phosphorylate NDPK and (b) detecting a change in a characteristic of the enzyme which differs between its phosphorylated and unphosphorylated forms. This may be aided by labelling the enzyme. Quantitative data can be obtained. Both in vivo and in vitro measurements can be made.
    Type: Grant
    Filed: February 18, 2004
    Date of Patent: November 20, 2007
    Assignee: Medical Research Council
    Inventors: Martin Hermann Klemens Brune, John Edgar Thomas Corrie, Martin Ronald Webb
  • Publication number: 20040248079
    Abstract: Nucleoside diphosphates (NDPs) are detected or measured by following the dephosphorylation of the phosphoenzyme form of nucleoside diphosphate kinase (NDPK), and nucleoside triphosphates (NTPs) are detected or measured by following the phosphorylation of NDPK to its phosphoenozyme form. A typical process involves (a) causing NDP in sample to bind to NDPK phosphoenzyme, or causing NTP in sample to phosphorylate NDPK and (b) detecting a change in a charateristic of the enzyme which differs between its phosphorylated and unphosphorylated forms. This may, be aided by labelling the enzyme. Quantitative data can be obtained. Both in vivo and in vitro measurements can be made.
    Type: Application
    Filed: February 18, 2004
    Publication date: December 9, 2004
    Inventors: Martin Hermann Klemens Brune, John Edgar Thomas Corrie, Martin Ronald Webb
  • Patent number: 6746849
    Abstract: Nucleoside diphosphates (NDPs) are detected or measured by following the dephosphorylation of the phosphoenzyme form of nucleoside diphosphate kinase (NDPK), and nucleoside triphosphates (NTPs) are detected or measured by following the phosphorylation of NDPK to its phosphoenzyme form. A typical process involves (a) causing NDP in sample to bind to NDPK phosphoenzyme, or causing NTP in sample to phosphorylate NDPK and (b) detecting a change in a characteristic of the enzyme which differs between its phosphorylated and unphosphorylated forms. This may be aided by labelling the enzyme. Quantitative data can be obtained. Both in vivo and in vitro measurements can be made.
    Type: Grant
    Filed: November 14, 2001
    Date of Patent: June 8, 2004
    Assignee: Medical Research Council
    Inventors: Martin Hermann Klemens Brune, John Edgar Thomas Corrie, Martin Ronald Webb
  • Patent number: 5898069
    Abstract: Disclosed is a method for measuring or detecting inorganic phosphate ion in a sample. In the method, a sample is reacted with a phosphate-binding protein containing (i) an inorganic phosphate ion binding site and (ii) a detectable label that produces a signal whose amplitude changes detectably upon the binding of inorganic phosphate ion to the binding site, under conditions effective to allow binding of phosphate in the sample to the binding site. From a change in signal, the level of inorganic phosphate ion is measured or detected. Also disclosed are phosphate binding proteins for use in the method.
    Type: Grant
    Filed: April 24, 1996
    Date of Patent: April 27, 1999
    Assignee: Medical Research Council
    Inventors: Martin Ronald Webb, Martin Hermann Brune, John Edgar Thomas Corrie